Cannabis and Chemotherapy Side Effects

Not Medical Advice

This article is not medical advice. It summarizes published evidence as of 2024. Cancer treatment is individualized, cannabis can interact with chemotherapy drugs, and what's appropriate for one patient may be harmful for another. Discuss any cannabis use — including CBD — with your oncologist and pharmacist before starting. Tell them honestly what you are taking, in what form, and how often. They have seen it before and would rather know.

Plain-language summary

Chemotherapy causes a cluster of miserable side effects: nausea and vomiting, pain, fatigue, appetite loss, neuropathy (nerve pain in hands and feet), anxiety, and insomnia. Cannabis — both the plant and pharmaceutical cannabinoids like dronabinol and nabilone — has been studied for several of these.

The short version:

• Nausea and vomiting: Synthetic THC pills (dronabinol, nabilone) work and are FDA-approved for this. They're typically used when standard anti-nausea drugs fail. Strong evidence
• Pain: Modest benefit at best. Cannabinoids reduce pain scores a little, but so does placebo. Weak / limited
• Neuropathy: Inhaled cannabis has shown some benefit in small trials for non-cancer neuropathy. Chemo-induced neuropathy specifically: not well studied. Weak / limited
• Appetite: Better evidence in HIV wasting than in cancer cachexia. Weak / limited
• Killing cancer: Lab and animal studies are intriguing. Human evidence does not exist at a level that should change treatment decisions. No data

Nobody should stop chemotherapy in favor of cannabis. That is the single most important sentence in this article.

What probably works

Synthetic THC for chemotherapy-induced nausea and vomiting (CINV). Dronabinol (Marinol) and nabilone (Cesamet) are FDA-approved oral cannabinoids for CINV that hasn't responded to conventional antiemetics ^[1]. Meta-analyses of trials from the 1980s onward show cannabinoids outperform placebo and several older antiemetics for nausea control ^[2]. Strong evidence

Important caveats: most of these trials predate modern antiemetics like ondansetron and the NK1-receptor antagonists (e.g., aprepitant), which are now first-line. Cannabinoids today are generally a second- or third-line option when standard regimens fail ^[1]. Whether smoked or vaporized whole-plant cannabis matches synthetic THC for CINV is plausible but not rigorously established — the controlled trial data is overwhelmingly on pill formulations ^[2]. Weak / limited for inhaled cannabis specifically.

The National Academies of Sciences, Engineering, and Medicine's 2017 review concluded there is conclusive or substantial evidence that oral cannabinoids are effective antiemetics in CINV ^[3].

What might work

Cancer pain. Nabiximols (Sativex, a 1:1 THC:CBD oromucosal spray) has been studied as add-on therapy for opioid-refractory cancer pain. Results are mixed: some Phase II trials showed benefit, but larger Phase III trials largely failed to meet their primary endpoints ^[4]. The honest read is a small effect in some patients, no effect in most. Weak / limited

Sleep and anxiety during treatment. Patients consistently report improvement, and short-term THC and CBD have biological plausibility here, but high-quality trials in oncology populations specifically are sparse. Anecdote to Weak / limited

Chemotherapy-induced peripheral neuropathy (CIPN). Cannabis has shown modest benefit in trials of non-cancer neuropathic pain (HIV neuropathy, diabetic neuropathy) ^[5]. Direct trials in CIPN are few and small. Extrapolation is reasonable but not proven. Weak / limited

Appetite stimulation / cachexia. Dronabinol increases appetite in HIV-related wasting [evidence:strong for HIV]. In cancer cachexia, results are less impressive — one major trial found cannabis extract no better than placebo for appetite or quality of life in advanced cancer patients ^[6]. Weak / limited

What doesn't work, or has weak evidence

Cannabis as a cancer treatment. This is the most important section. Preclinical studies — cells in dishes and tumors in mice — have shown that cannabinoids can slow growth or trigger death in some cancer cell lines ^[7]. This is interesting science. It is not evidence that cannabis cures cancer in humans. No randomized controlled trial has demonstrated that cannabis shrinks tumors or extends survival in cancer patients. No data for human anti-tumor effects.

Patients who replace chemotherapy or radiation with cannabis oil ('Rick Simpson Oil,' RSO) are taking a real risk based on social media claims and a small number of unreplicated case reports. Several published case series have documented patients with curable cancers who declined standard treatment in favor of cannabis and died of progression ^[8].

Specific strains for specific cancers. No evidence. The 'indica vs. sativa' framework does not map to clinical outcomes, and claims that a particular cultivar treats a particular tumor are marketing. No data

CBD-only products for chemo nausea. The antiemetic evidence is for THC. CBD alone has not been shown to control CINV. [evidence:weak/none]

What we don't know

• Optimal dose, ratio (THC:CBD), and route for any oncology indication.
• Whether vaporized flower performs as well as oral synthetic THC for CINV.
• Long-term effects of daily cannabis use during multi-cycle chemotherapy.
• Whether cannabis affects chemotherapy efficacy (some retrospective data in immunotherapy patients is concerning — see Risks).
• Whether CBD meaningfully reduces chemotherapy-induced neuropathy.
• Pediatric oncology use, beyond severe refractory epilepsy.

Comparison with standard treatments

For CINV, modern standard care is a combination of a 5-HT3 antagonist (ondansetron, palonosetron), a steroid (dexamethasone), and for highly emetogenic regimens, an NK1 antagonist (aprepitant) and sometimes olanzapine. These work well for most patients. Cannabinoids are added when this regimen fails, or for breakthrough nausea ^[1].

For cancer pain, opioids remain first-line for moderate-to-severe pain, with adjuvants like gabapentinoids for neuropathic components. Cannabis is, at best, an adjunct that may allow modest opioid sparing in some patients — not a replacement.

For appetite, megestrol acetate and corticosteroids have more evidence in cancer cachexia than cannabinoids, though all have limited efficacy and side effects.

The practical role of cannabis in oncology supportive care is: a reasonable add-on for patients whose symptoms aren't controlled by standard treatment, used with the oncology team's knowledge.

Risks and interactions

Drug interactions. CBD (and to a lesser extent THC) inhibits cytochrome P450 enzymes — particularly CYP3A4 and CYP2C19 — that metabolize many chemotherapy drugs, including tamoxifen, cyclophosphamide, vincristine, and several tyrosine kinase inhibitors ^[9]. This can raise or lower drug levels unpredictably. Tell your oncology pharmacist what you're using.

Immunotherapy. A retrospective study suggested cannabis use was associated with reduced response rates to nivolumab (a checkpoint inhibitor) in cancer patients ^[10]. This is preliminary and not proof of causation, but it's enough reason for patients on immunotherapy to discuss cannabis with their oncologist before continuing.

Infection risk. Patients on chemotherapy are often immunocompromised. Smoked cannabis can carry fungal contaminants (Aspergillus) and bacteria. Inhalation routes carry the highest risk; tested edibles or pharmaceutical formulations are safer choices during neutropenia.

Cardiovascular. THC increases heart rate and can lower blood pressure — relevant for patients on cardiotoxic chemotherapy (anthracyclines).

Psychiatric. THC can trigger anxiety, paranoia, and in vulnerable individuals psychotic symptoms. Patients already coping with a cancer diagnosis don't need an extra panic attack.

Falls and confusion. Especially in older patients or those on opioids and benzodiazepines.

None of this means cannabis is off-limits during chemotherapy. It means it's a real drug, with real effects, and deserves to be managed like one.

Sources

How this page was made

Related

• Cannabis and Cancer Pain — An honest look at what cannabis can and cannot do for pain in people with cancer, sorted b...